will semaglutide prices go down Do the New Obesity Drugs Pay for Themselves? Novo Nordisk slashes price of

Federal Efforts to Regulate PBMs In February 2026, Congress enacted legislation that will address some PBM business practices, including: Delinking PBM compensation from the price of a drug, or any rebates or discounts that they negotiate for drug plans under Medicare Part D and instead basing compensation on a bona fide service fee, which will be a flat dollar amount that reflects the fair market value of services provided by PBMs, beginning January 1, 2028

Case Study 2: Managing Co-Occurring Medical and ED Needs Client Profile: A 25-year-old female presenting with OSFED, Major Depressive Disorder, and Generalized Anxiety Disorder, admitted to PHP to manage mood, anxiety, and ED symptoms

GHK-Cu - ,

Research applications focus on slow-wave sleep promotion, stress hormone balance, and the neuroprotective properties of the peptide